CClinicalTrials.gg
CompletedNCT02786121kinesiofobUpdated Aug 7, 2017

The Role of Kinesiophobia in the Functional Recovery After Hip Replacement

An observational study in Hip Osteoarthritis, sponsored by Istituto Ortopedico Rizzoli. Completed at 1 site in Italy. Open to participants aged 18 Years to 75 Years. Per ClinicalTrials.gov, last updated 2017-08-07.

Sponsored by Istituto Ortopedico Rizzoli · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
200
Ages
18 Years to 75 Years
Sex
All
01

Study summary

Several authors explain as the kinesiophobia plays an important role for the recovery after orthopaedic surgery. The aim of the investigators study is to investigate if the kinesiophobia is able to influence the early recovery after total hip arthroplasty. The early recovery will be measured by the ILOA Score. The Tampa Scale of Kinesiophobia will measure the fear level of movement. All the other variable that could influence the ILOA Score are identified and collected: age, sex, body max index, ability of patient pre-surgery, type of anesthesia, length of stay, pain, haemoglobin, possible complications.

02

Conditions studied

  • Hip Osteoarthritis

Keywords

  • hip replacement,
  • rehabilitation,
  • early ambulation,
03

In context

Osteoarthritis, Hip

628 studies on the registry are indexed under Osteoarthritis, Hip; 121 are open to participants now.

This study's enrollment of 200 is above the median of 141 across 154 observational studies indexed under Osteoarthritis, Hip.

Browse Osteoarthritis, Hip studies →

Lead sponsor

Istituto Ortopedico Rizzoli is the lead sponsor of 298 studies on the registry; 102 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Total hip arthroplasties patients following chronic joint disease

Inclusion criteria

  • Primary hip joint replacement
  • Clinical symptoms from more than 3 months

Exclusion criteria

Exclusion Criteria:

  • other orthopaedic surgery on the lower limb In the last year
  • Not italian speaking
  • Hip arthroplasty following fractures, revision surgery, and partial replacement
  • Patients with concomitant neurologic (Parkinson, ictus), rheumatologic (rheumatoid arthritis) diseases,
  • cognitive impaired.
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
200 participants (actual)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Iowa Level of Assistance (ILOA) Score

    The outcome considered was the level of autonomy achieved by the patients at the 5th days after surgery, measured by the Iowa Level of Assistance (ILOA) scale that took into account the patient's autonomy in carrying out functional 5 activities: supine-to-sitting, sitting-to-standing, walking, climbing 3 steps, and gait speed. The total score ranged from 0 to 50, where 0 was the patient's complete autonomy and 50 the maximum dependence. The score was based on the level of help that was supplied to the patient by the operator for the safe execution of activities, with a range between 0 and 30, and the type of assistive device used with a range between 0 and 20. The physiotherapist will collect the ILOA Score.

    Time frame: 5 days after surgery

07

Study locations

1 site
  • Istituto Ortopedico Rizzoli
    Bologna, 40136, Italy
08

References and documents

Publications

  • Morri M, Venturini E, Franchini N, Ruisi R, Culcasi A, Ruggiero A, Govoni C, Benedetti MG. Is kinesiophobia a predictor of early functional performance after total hip replacement? A prospective prognostic cohort study. BMC Musculoskelet Disord. 2020 Nov 7;21(1):724. doi: 10.1186/s12891-020-03748-7. PubMed 33160343 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 7, 2017, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02786121
Lead sponsor
Istituto Ortopedico Rizzoli
Responsible party
Sponsor
First posted
May 30, 2016
Start date
Apr 2016
Primary completion
Apr 2017
Completion
May 2017
Last update
Aug 7, 2017

Study contacts

Mattia Morri
principal investigator · Istituto Ortopedico Rizzoli

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion